Dallas-based Dean Omar Branham Shirley is handling another talcum powder trial against Johnson & Johnson, which began on ...

(Reuters) -A state judge in Oregon has overturned a jury's $260 million verdict against Johnson & Johnson in a lawsuit brought by a woman who said she got mesothelioma, a deadly cancer linked to ...

A court tossed out a $223 million jury award to four plaintiffs who claimed they developed cancer from using Johnson & Johnson's baby powder.

The ruling comes as J&J is gearing up to face a spate of jury trials early next year over allegations its executives knew since the early 1970s their talc contained trace amounts of asbestos, but ...

Johnson & Johnson JNJ announced that a bankruptcy court in Texas has rejected its bankruptcy plan to resolve talc lawsuits for the third time. J&J faces more than 62,000 lawsuits for its talc ...

The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman who developed mesothelioma, a rare and aggressive cancer linked to asbestos exposure.

Johnson & Johnson moved to dismiss an amended, proposed class action alleging the company engaged in fraudulent transfers to cheat talc litigation plaintiffs of recoveries.

Some legal experts say Tuesday's verdict could make it harder for Johnson & Johnson to finalize its proposed $8.9 billion settlement in the Chapter 11 talc case.

J&J wants to use Chapter 11 proceedings because bankruptcy judges can enforce global settlements that permanently halt all related lawsuits and forbid new ones, all for a capped payout.

J&J has maintained that its now-discontinued talc products are safe and do not cause cancer. It previously set aside $400 million to resolve state claims.

Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm ...